Sign In
Learn bits
Health & Medicine
Pradeep Kumar

09/05/21 09:20 AM IST

Anti-COVID drug developed by DRDO

In news

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO)

About the drug
  • The drug comes in powder form in a sachet and is taken orally by dissolving it in water.
  • It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production.
  • Its selective accumulation in virally infected cells makes this drug unique.
  • Clinical trial results of the drug have shown that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.
  • A higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in COVID patients.
Source: PIB, The Hindu

More Related Current Affairs View All

23 Sep

Quad grouping

'Prime Minister Narendra Modi arrived in the United States, where he will participate in the fourth Quad Leaders Summit in Wilmington, Delaware.' Quad s the grouping of four de

Read More

21 Sep

India Achieves Tier 1 Status in Global Cybersecurity Index 2024

' India has secured Tier 1 status in the Global Cybersecurity Index (GCI) 2024, published by the International Telecommunication Union (ITU).' The GCI is a comprehensive assessm

Read More

21 Sep

A new White Revolution

'Operation Flood, launched in 1970, ushered in the White Revolution and transformed the dairy sector in India.' Dairy cooperatives procured 660 lakh kg of milk per day in 2023-2

Read More

India’s First Ai-Driven Magazine Generator

Generate Your Custom Current Affairs Magazine using our AI in just 3 steps